12-132606190-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000376608.9(LRCOL1):āc.62T>Cā(p.Met21Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000169 in 1,536,518 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 10/13 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000376608.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LRCOL1 | NM_001195520.2 | c.62T>C | p.Met21Thr | missense_variant | 2/6 | ENST00000376608.9 | NP_001182449.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LRCOL1 | ENST00000376608.9 | c.62T>C | p.Met21Thr | missense_variant | 2/6 | 1 | NM_001195520.2 | ENSP00000479730 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152122Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000148 AC: 2AN: 135366Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 73658
GnomAD4 exome AF: 0.0000181 AC: 25AN: 1384396Hom.: 0 Cov.: 30 AF XY: 0.0000117 AC XY: 8AN XY: 683152
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152122Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74314
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 27, 2022 | The c.62T>C (p.M21T) alteration is located in exon 2 (coding exon 1) of the LRCOL1 gene. This alteration results from a T to C substitution at nucleotide position 62, causing the methionine (M) at amino acid position 21 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at